Is Eaton Vance Municipal Income 2028 Term Trust (ETX) a Buy, Sell, or Hold?
NYSE : ETX
Eaton Vance Municipal Income 2028 Term Trust
$18.54 USD
-$0.04 (-0.22%)
- Volume
- 18.15K
- Average Volume
- 13.58K
- Market Capitalization
- $201.85M
- P/E Ratio
- 24.08
- Dividend Yield
- 5.06%
- Price Target
- Year High
- $20.00
- Year Low
- $18.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.21
Company Overview
NYSE
Payson F. Swaffield
Asset Management - Income
Financial Services
ETX
N/A
US
USD
617-482-8260
27829U105
0001563696
Liquidity Metrics
0.03
2.21
2.21
0.00
0.00
Sales & Valuation
$9.01M
22.71
1.00
0.00
0.00
Profitability
$0.78
$8.47M
95.26%
95.26%
4.21%
4.04%
P/E Metrics
24.08
0.92
0.92
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
14.93
6/9
$1.81M
$209.6M
$8.33M
$15.8M
Key Metrics (TTM)
$208.52M
23.46
24.63
2.21
4.21%
4.07%
4.19%
0.00%
$17.97
74 days
Company Executives
| Name | Title |
|---|---|
| Craig Robert Brandon | Portfolio Manager |
| Payson F. Swaffield | Vice President, Chief Income Investment Officer & Portfolio Manager |
Poll Results
No votes yet today — be the first to share your view!
About Eaton Vance Municipal Income 2028 Term Trust (NYSE:ETX) Stock
The Eaton Vance Municipal Income 2028 Term Trust is a closed-end mutual fund, initiated and actively managed by Eaton Vance Management. This fund primarily allocates capital to fixed-income instruments, with a particular focus on generating municipal income. It was established on March 28, 2013, within the United States. Prior to its current designation, the trust operated under the name Eaton Vance Municipal Income Term Trust. ...
2026-05-13 06:00:00
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #ASGCT2026--Encoded Therapeutics, Inc. (“Encoded”), a clinical‑stage biotechnology company developing precision genetic medicines for severe neurological disorders, today will present an expanded dataset from the ongoing POLARIS Phase 1/2 trials of ETX101, its investigational AAV9‑based gene regulation therapy designed as a one‑time, disease‑modifying treatment for SCN1A+ Dravet syndrome. The update includes additional patients, early data from the top dose lev.
Frequently Asked Questions
-
What is the current Eaton Vance Municipal Income 2028 Term Trust (ETX) stock price?
-
Eaton Vance Municipal Income 2028 Term Trust(NYSE:ETX) stock price is $18.54 in the last trading session. During the trading session, ETX stock reached the peak price of $20 while $18.05 was the lowest point it dropped to. The percentage change in ETX stock occurred in the recent session was --0.22% while the dollar amount for the price change in ETX stock was -$0.04.
-
ETX's industry and sector of operation?
-
The NYSE listed ETX is part of Asset Management - Income industry that operates in the broader Financial Services sector.
-
Who are the executives of ETX?
-
Craig Robert Brandon | Portfolio Manager
Payson F. Swaffield | Vice President, Chief Income Investment Officer & Portfolio Manager
|
|
| -
How many employees does ETX have?
-
Number of ETX employees currently stands at None. ETX operates from One Post Office Square, Boston, MA 02110, US.
-
Link for ETX official website?
-
Official Website of ETX is: https://funds.eatonvance.com/Municipal-Income-2028-Term-Trust-ETX.php
-
How do I contact ETX?
-
ETX could be contacted at phone #617-482-8260 and can also be accessed through its website. ETX operates from One Post Office Square, Boston, MA 02110, US.
-
How many shares of ETX are traded daily?
-
The average number of ETX shares traded daily for last 3 months was 13.58K.
-
What is the market cap of ETX currently?
-
The market value of ETX currently stands at $201.85M with its latest stock price at $18.54